Euda Health Holdings Limited Dossier
Qualitative Analysis
Business overview
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider operating primarily in Singapore, Malaysia, and China. The company focuses on inventive, accessible, and science-based health solutions to support the regional shift from reactive medical treatment to proactive, longevity-focused care. EUDA operates in two reportable segments: holistic wellness consumer products and services, and property management services (which includes management and security services for condominiums, residential apartments, business office buildings, and shopping malls).
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Establishing a dedicated stem cell therapy platform and opening the inaugural clinic in Shenzhen, China, to focus on advanced non-invasive treatments and longevity-focused care.
Expected impact: Positions EUDA as a key player in advanced healthcare technologies and expands its geographic footprint into mainland China.
Expanding the Helix product line by securing exclusive global distribution rights for products from Chemokine Pte Ltd, starting with the Regenix iPSC-derived Skin Stem Cell Secretome Mask.
Expected impact: Diversifies revenue streams into the high-growth skincare and wellness market across the Asia-Pacific region, particularly in Malaysia and China.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Expands EUDA's wellness product portfolio and strengthens its direct-selling presence in Malaysia, Vietnam, and Indonesia.
Financial impact: Contributed approximately 2.2% of total revenue ($89,023) for the fiscal year ended December 31, 2024, with expectations of scaling up.
Strategic Partnerships
Grants EUDA exclusive global distribution rights for Helix products, including the Regenix iPSC-derived Skin Stem Cell Secretome Mask.
Terms: Not disclosed
Enables CK Health to offer stem cell therapy services in Singapore and Malaysia through Key Lock, an authorized distributor of Guangdong Cell Biotech.
Terms: Not disclosed